Researchers found patients with CHSS-catheters experienced zero CRBSIs per 1,000 patient days, while patients with standard catheters experienced 5.01 CRBSIs per 1,000 patient days.
Additionally, CHSS-catheters were associated with a lower CVC-related cost per day than standard catheters, at $5.21 and $10.03 (converted from Euros), respectively.
Researchers concluded CHSS-catheters led to reduced CRBSIs and lower costs.
More Articles on Infection Control:
Stethoscopes: New Culprit in MRSA Transmission
CDC: New Vancomycin-resistant Strep Strains Have Appeared
To Prevent MRSA, Healthcare Workers Want Clarified Protocols
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
